Guo, R., Xie, Y., Yang, J., Lu, H., Ye, P., Jin, L., & Lin, W. (2019). Increasing plasma ADAMTS13 activity is associated with HBeAg seroconversion in chronic hepatitis B patients during 5 years of entecavir treatment. Sci Rep.

Guo, Renyong, Yirui Xie, Jiezuan Yang, Haifeng Lu, Ping Ye, Linfeng Jin, et Wenqin Lin. "Increasing Plasma ADAMTS13 Activity Is Associated With HBeAg Seroconversion in Chronic Hepatitis B Patients During 5 Years of Entecavir Treatment." Sci Rep 2019.

Guo, Renyong, et al. "Increasing Plasma ADAMTS13 Activity Is Associated With HBeAg Seroconversion in Chronic Hepatitis B Patients During 5 Years of Entecavir Treatment." Sci Rep 2019.